monitored the interactions between untreated and treated CRC tumor cells and interferon-α-conditioned dendritic cells (IFN-DCs)—a potential cancer therapeutic with the ability to uptake cancer antigens, stimulate a T cell response, and phagocytose tumor cells—in a 3D microfluidic model (Figure 1B). This evidence concerns the gene IFNA1 and neoplasm.